Please login to the form below

Not currently logged in
Email:
Password:

allergies

This page shows the latest allergies news and features for those working in and with pharma, biotech and healthcare.

Fauci addresses need for pan-coronavirus and intranasal vaccines to combat COVID-19 variants

Fauci addresses need for pan-coronavirus and intranasal vaccines to combat COVID-19 variants

The National Institute of Allergy and Infectious Diseases (NIAID) director specifically detailed the call for pan-coronavirus candidates and mucosal options that can be given to patients intranasally, all the while

Latest news

More from news
Approximately 17 fully matching, plus 241 partially matching documents found.

Latest Intelligence

  • The pandemic preparedness paradox The pandemic preparedness paradox

    In the United States, the National Institute of Allergy and Infectious Diseases alone spends $6bn annually in the labs of some of the best and brightest scientists in the world.

  • The search for effective drug treatments for COVID-19 The search for effective drug treatments for COVID-19

    medicine. to contribute to the medical response in public health emergencies. The EUA was based on then available data from two global clinical trials – the National Institute for Allergy and Infectious

  • Exploring the potential of eosinophils Exploring the potential of eosinophils

    when starting his research career in Southampton, UK before going on to be Professor of Allergy and Respiratory Medicine at Southampton University. ... Working as a clinician at this time meant he was caring for patients with allergies and asthma, in

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    I don’t think the ongoing trials will tell us a lot,” said H Clifford Lane, clinical director at the National Institutes of Allergy and Infectious Diseases (NIAID).

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    This year’s list also highlights three first-in class medicines compared with last year’s list, which contained only one first-in-class medicine, peanut allergy vaccine Palforzia.

More from intelligence
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 14 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...